Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04231825
Other study ID # 18-26268-1
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 15, 2019
Est. completion date September 15, 2020

Study information

Verified date March 2022
Source University of California, San Francisco
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal is to replicate in-lab results from transcranial alternating current stimulation (tACS) with at-home tACS.


Description:

Participants will be assessed in-lab on multitasking and sustained attention abilities. Participants will be sent home with a tACS device to be used at-home for five days while engaged in a multitasking paradigm that is different from the multitasking outcome measure used pre/post tACS. After the at-home stimulation is complete, participants return to UCSF for a final in-lab assessment of multitasking and sustained attention ability.


Recruitment information / eligibility

Status Completed
Enrollment 47
Est. completion date September 15, 2020
Est. primary completion date August 15, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria: - English speaking - Grade 12 or more education - Normal or corrected to normal vision and hearing - Ability to complete cognitive tasks - Ability to cooperate and comply with all study procedures - Ability to tolerate tACS Exclusion Criteria: - Neurological or psychiatric disorders - Family history of epilepsy - History of seizures - Prior head trauma - Pregnant - Implanted electronic devices (e.g., pacemaker) - IQ < 80 - Taking psychotropic medication - Taking anti-depressants or anti-anxiety medication - Substance abuse - Color blind - Glaucoma - Macular degeneration - Amblyopia - Strabismus

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Transcranial alternating current stimulation
Transcranial alternating current stimulation across the prefrontal cortex using electrodes F3 and F4.

Locations

Country Name City State
United States Sandler Neurosciences Center San Francisco California

Sponsors (1)

Lead Sponsor Collaborator
University of California, San Francisco

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Multitasking Performance Cost (Neuroracer Performance Change From Baseline) Assessment of multitasking ability using change from baseline scores in d' cost (metric of discriminability). Discrimination performance (d') was measured for each participant by comparing hit (correct responses to target signs) rates and false alarm (responses to non-targets) rates and calculated as d' = Z (hits) - Z (false alarms). d' cost was then calculated as the ratio of d' during single task target discrimination task to multitask target discrimination, expressed as percentage cost. Pre-tACS and post-tACS (1 week later)
Primary Single Task Performance Change Discrimination performance (d') was measured during single task performance for each participant by comparing hit (correct responses to target signs) rates and false alarm (responses to non-targets) rates and calculated as d' = Z (hits) - Z (false alarms). Performance data was collected during the single task condition. Pre-tACS and post-tACS (1 week later)
Primary Multitask Performance Change Discrimination performance (d') was measured while multitasking for each participant by comparing hit (correct responses to target signs) rates and false alarm (responses to non-targets) rates and calculated as d' = Z (hits) - Z (false alarms). Performance data was collected during the multitask condition. Pre-tACS and post-tACS (1 week later)
Secondary Continuous Performance Test RT Change (Test of Visual Attention / Sustained Attention) Assessment of sustained attention ability using response time (in ms) during the continuous performance test Pre-tACS and post-tACS (1 week later)
Secondary Continuous Performance Test RTV Change (Test of Visual Attention / Sustained Attention) Assessment of sustained attention ability using response time variability (standard deviation of response times in ms) during the continuous performance test Pre-tACS and post-tACS (1 week later)
See also
  Status Clinical Trial Phase
Recruiting NCT06066619 - Can Cranberry Juice Enhance the Cognition Accuracy and Alleviate Negative Mental Consequences During Multitasking? N/A